Magnetic resonance spectroscopy in the assessment of pilocytic astrocytomas |
| |
Authors: | Harris Lisa M Davies Nigel P Macpherson Lesley Lateef Shaheen Natarajan Kal Brundler Marie-Anne Sgouros Spyros English Martin W Arvanitis Theodoros N Grundy Richard G Peet Andrew C |
| |
Affiliation: | Department of Academic Paediatrics and Child Health, University of Birmingham, Birmingham, UK. |
| |
Abstract: | BackgroundPilocytic astrocytomas (PA) are common childhood brain tumours whose management and prognosis vary widely depending on location. 1H magnetic resonance spectroscopy (MRS) measures biochemistry in vivo and shows promise for characterising brain tumours and aiding management.MethodsSingle voxel MRS (1.5 Tesla, TE 30 ms, TR 1500 ms) was performed on 27 children with PAs. Cases were designated ‘progressors’ if tumour progression led to their clinical management plan being altered.ResultsPrior to treatment, supratentorial tumours had significantly higher myo-inositol (p < 0.01, t-test) and glutamate plus glutamine (p = 0.02, t-test) than cerebellar tumours. Optic pathway or thalamic tumours that progressed had a significantly (p = 0.04, t-test) lower myo-inositol at initial MRS than those with stable disease. Myo-inositol levels decreased significantly in progressors between the initial and subsequent MRS (p = 0.03, paired t-test). Changes in myo-inositol occurred before clinical and radiological progression.ConclusionsMRS identifies differences with anatomical location in PAs and yields potential non-invasive biomarkers of prognosis. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|